These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9665490)

  • 1. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region.
    Wu TT; Watanabe T; Heitmiller R; Zahurak M; Forastiere AA; Hamilton SR
    Am J Pathol; 1998 Jul; 153(1):287-94. PubMed ID: 9665490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
    van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
    Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma.
    Blount PL; Meltzer SJ; Yin J; Huang Y; Krasna MJ; Reid BJ
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3221-5. PubMed ID: 8475062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic and molecular analysis of high-grade dysplasia and early adenocarcinoma in short- versus long-segment Barrett esophagus.
    Nobukawa B; Abraham SC; Gill J; Heitmiller RF; Wu TT
    Hum Pathol; 2001 Apr; 32(4):447-54. PubMed ID: 11331963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction.
    Moskaluk CA; Heitmiller R; Zahurak M; Schwab D; Sidransky D; Hamilton SR
    Hum Pathol; 1996 Nov; 27(11):1211-20. PubMed ID: 8912833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma.
    Blount PL; Ramel S; Raskind WH; Haggitt RC; Sanchez CA; Dean PJ; Rabinovitch PS; Reid BJ
    Cancer Res; 1991 Oct; 51(20):5482-6. PubMed ID: 1680552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
    Galipeau PC; Prevo LJ; Sanchez CA; Longton GM; Reid BJ
    J Natl Cancer Inst; 1999 Dec; 91(24):2087-95. PubMed ID: 10601379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of neoplastic cell lineages in Barrett oesophagus.
    Barrett MT; Sanchez CA; Prevo LJ; Wong DJ; Galipeau PC; Paulson TG; Rabinovitch PS; Reid BJ
    Nat Genet; 1999 May; 22(1):106-9. PubMed ID: 10319873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy.
    Blount PL; Galipeau PC; Sanchez CA; Neshat K; Levine DS; Yin J; Suzuki H; Abraham JM; Meltzer SJ; Reid BJ
    Cancer Res; 1994 May; 54(9):2292-5. PubMed ID: 8162566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction.
    Koppert LB; Wijnhoven BP; Tilanus HW; Stijnen T; Van Dekken H; Dinjens WN
    Int J Surg Pathol; 2004 Apr; 12(2):117-25. PubMed ID: 15173916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal imbalances in gastric and esophageal adenocarcinoma: specific comparative genomic hybridization-detected abnormalities segregate with junctional adenocarcinomas.
    Stocks SC; Pratt N; Sales M; Johnston DA; Thompson AM; Carey FA; Kernohan NM
    Genes Chromosomes Cancer; 2001 Sep; 32(1):50-8. PubMed ID: 11477661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.
    Feith M; Stein HJ; Mueller J; Siewert JR
    Dis Esophagus; 2004; 17(4):322-7. PubMed ID: 15569371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic analysis of Barrett's esophagus after ablative therapy: persistence of genetic alterations at tumor suppressor loci.
    Hage M; Siersema PD; Vissers KJ; Dinjens WN; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
    Int J Cancer; 2006 Jan; 118(1):155-60. PubMed ID: 16032707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma.
    Demicco EG; Farris AB; Baba Y; Agbor-Etang B; Bergethon K; Mandal R; Daives D; Fukuoka J; Shimizu M; Dias-Santagata D; Ogino S; Iafrate AJ; Gaissert HA; Mino-Kenudson M
    Mod Pathol; 2011 Sep; 24(9):1177-90. PubMed ID: 21572404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic loss involving the tumor suppressor genes APC and MCC and expression of the APC protein in the development of dysplasia and carcinoma in Barrett esophagus.
    Bektas N; Donner A; Wirtz C; Heep H; Gabbert HE; Sarbia M
    Am J Clin Pathol; 2000 Dec; 114(6):890-5. PubMed ID: 11338478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma.
    Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Russell SE
    Cancer Res; 1995 Aug; 55(15):3406-11. PubMed ID: 7614480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples.
    van Nistelrooij AM; van Marion R; Koppert LB; Biermann K; Spaander MC; Tilanus HW; van Lanschot JJ; Wijnhoven BP; Dinjens WN
    BMC Res Notes; 2017 Apr; 10(1):144. PubMed ID: 28376920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losses of heterozygosity on chromosomes 9p and 17p are frequent events in Barrett's metaplasia not associated with dysplasia or adenocarcinoma.
    Suspiro A; Pereira AD; Afonso A; Albuquerque C; Chaves P; Soares J; Leitão CN
    Am J Gastroenterol; 2003 Apr; 98(4):728-34. PubMed ID: 12738448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
    Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
    Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
    Abraham SC; Wang H; Wang KK; Wu TT
    Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.